PCNT (pericentrin)

2007-02-01  

Identity

HGNC
LOCATION
21q22.3
LOCUSID
ALIAS
KEN,MOPD2,PCN,PCNT2,PCNTB,PCTN2,SCKL4
FUSION GENES

Other Information

Locus ID:

NCBI: 5116
MIM: 605925
HGNC: 16068
Ensembl: ENSG00000160299

Variants:

dbSNP: 5116
ClinVar: 5116
TCGA: ENSG00000160299
COSMIC: PCNT

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000160299ENST00000359568O95613
ENSG00000160299ENST00000418394H7C2A3

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Organelle biogenesis and maintenanceREACTOMER-HSA-1852241
Cilium AssemblyREACTOMER-HSA-5617833
Anchoring of the basal body to the plasma membraneREACTOMER-HSA-5620912
Cell CycleREACTOMER-HSA-1640170
Cell Cycle, MitoticREACTOMER-HSA-69278
Mitotic G2-G2/M phasesREACTOMER-HSA-453274
G2/M TransitionREACTOMER-HSA-69275
Regulation of PLK1 Activity at G2/M TransitionREACTOMER-HSA-2565942
Centrosome maturationREACTOMER-HSA-380287
Recruitment of mitotic centrosome proteins and complexesREACTOMER-HSA-380270
Loss of proteins required for interphase microtubule organization from the centrosomeREACTOMER-HSA-380284
Loss of Nlp from mitotic centrosomesREACTOMER-HSA-380259
AURKA Activation by TPX2REACTOMER-HSA-8854518

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
372113832023PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest.0
379376422023Pericentrin deficiency in smooth muscle cells augments atherosclerosis through HSF1-driven cholesterol biosynthesis and PERK activation.0
372113832023PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest.0
379376422023Pericentrin deficiency in smooth muscle cells augments atherosclerosis through HSF1-driven cholesterol biosynthesis and PERK activation.0
334600282021Identification of three novel mutations in PCNT in vietnamese patients with microcephalic osteodysplastic primordial dwarfism type II.2
342335842021Triple deletion of TP53, PCNT, and CEP215 promotes centriole amplification in the M phase.2
344186902021Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.2
334600282021Identification of three novel mutations in PCNT in vietnamese patients with microcephalic osteodysplastic primordial dwarfism type II.2
342335842021Triple deletion of TP53, PCNT, and CEP215 promotes centriole amplification in the M phase.2
344186902021Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.2
322552532020Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer.7
322671002020Microcephalic osteodysplastic primordial dwarfism type II: Additional nine patients with implications on phenotype and genotype correlation.5
325576212020Novel PCNT variants in MOPDII with attenuated growth restriction and pachygyria.3
327447762020Microcephalic osteodysplastic primordial dwarfism type II and pachygyria: Morphometric analysis in a 2-year-old girl.2
331702112020Centriole-independent mitotic spindle assembly relies on the PCNT-CDK5RAP2 pericentriolar matrix.20

Citation

Dessen P

PCNT (pericentrin)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46563/pcnt-(pericentrin)